What is the best approach to manage a patient with hypertensive urgency or emergency, particularly one with a history of resistant hypertension or heart failure?

Management of Hypertensive Urgency and Emergency

Critical First Step: Distinguish Emergency from Urgency

The presence or absence of acute target organ damage—not the absolute blood pressure number—determines whether immediate ICU admission with IV therapy is required or outpatient oral management is appropriate. 1, 2

Hypertensive Emergency (Requires ICU + IV Therapy)

• Definition: BP >180/120 mmHg WITH evidence of new or worsening target organ damage 1, 2
• Target organ damage includes: 1, 3
  • Neurologic: Hypertensive encephalopathy, intracranial hemorrhage, acute ischemic stroke
  • Cardiac: Acute MI, acute left ventricular failure with pulmonary edema, unstable angina
  • Vascular: Aortic dissection or aneurysm
  • Renal: Acute kidney injury, thrombotic microangiopathy
  • Ophthalmologic: Malignant hypertension with papilledema, hemorrhages, cotton wool spots
  • Obstetric: Severe preeclampsia/eclampsia
• Mortality without treatment: 79% at 1 year with median survival of only 10.4 months 1, 2

Hypertensive Urgency (Outpatient Management)

• Definition: Severe BP elevation (>180/120 mmHg) WITHOUT acute target organ damage 4, 2
• Examples: Severe headache, shortness of breath, epistaxis, severe anxiety without evidence of organ injury 4
• Key point: Up to one-third of patients with diastolic BP >95 mmHg normalize before follow-up, and rapid BP lowering may be harmful 1

---

Management of Hypertensive Emergency

Immediate Actions

• Admit to ICU immediately (Class I recommendation, Level B-NR) for continuous arterial line BP monitoring and parenteral therapy 1, 2
• Obtain focused diagnostic workup within minutes: 1, 3
  • Complete blood count (hemoglobin, platelets) to assess for microangiopathic hemolytic anemia
  • Basic metabolic panel (creatinine, sodium, potassium) to evaluate renal function
  • Lactate dehydrogenase (LDH) and haptoglobin to detect hemolysis
  • Urinalysis for protein and urine sediment examination
  • Troponins if chest pain present
  • ECG to assess for cardiac involvement
  • CT brain without contrast if neurologic symptoms present
  • Fundoscopy to identify papilledema, hemorrhages, or exudates

Blood Pressure Targets

Standard approach for most hypertensive emergencies: 1, 2

1. First hour: Reduce mean arterial pressure by 20-25% (or SBP by no more than 25%)
2. Next 2-6 hours: If stable, reduce to 160/100 mmHg
3. Next 24-48 hours: Cautiously normalize BP

Critical warning: Avoid excessive acute drops >70 mmHg systolic, as this can precipitate cerebral, renal, or coronary ischemia, particularly in patients with chronic hypertension who have altered autoregulation 1, 2

Exception—More aggressive targets for specific conditions: 1, 3

• Aortic dissection: SBP <120 mmHg AND heart rate <60 bpm within 20 minutes
• Acute coronary syndrome/pulmonary edema: SBP <140 mmHg immediately
• Intracerebral hemorrhage: SBP 140-160 mmHg immediately (within 6 hours)
• Eclampsia/severe preeclampsia: SBP <160 mmHg and DBP <105 mmHg immediately

First-Line IV Medications

Nicardipine is the preferred first-line agent for most hypertensive emergencies due to its predictable titration, maintenance of cerebral blood flow, and lack of increased intracranial pressure 1, 5, 6

Nicardipine Dosing 1, 5

• Initial dose: 5 mg/hr IV infusion
• Titration: Increase by 2.5 mg/hr every 5-15 minutes
• Maximum dose: 15 mg/hr
• Preparation: Dilute 25 mg vial with 240 mL compatible IV fluid to achieve 0.1 mg/mL concentration
• Administration: Via central line or large peripheral vein; change infusion site every 12 hours if peripheral
• Advantages: Rapid onset (5-10 minutes), predictable response, preserves cerebral blood flow
• Caution: Monitor for tachycardia and headache

Alternative First-Line Agents

Labetalol 1, 3

• Dose: 0.25-0.5 mg/kg IV bolus OR 2-4 mg/min continuous infusion, then 5-20 mg/hr maintenance
• Onset: 5-10 minutes
• Duration: 3-6 hours
• Preferred for: Malignant hypertension with renal involvement, hypertensive encephalopathy (preserves cerebral blood flow)
• Contraindications: Reactive airway disease, COPD, heart block, bradycardia, decompensated heart failure

Clevidipine 1, 7, 6

• Initial dose: 1-2 mg/hr IV infusion
• Titration: Double every 90 seconds until BP approaches target, then increase by less than double every 5-10 minutes
• Maximum dose: 32 mg/hr
• Advantages: Ultra-short acting, precise titration
• Contraindications: Soy/egg allergy, defective lipid metabolism

Condition-Specific Medication Selection

Acute coronary syndrome or pulmonary edema: 1, 3

• First-line: Nitroglycerin IV (5-10 mcg/min, titrate by 5-10 mcg/min every 5-10 minutes)
• Mechanism: Reduces preload and afterload, improves myocardial oxygen supply-demand ratio
• Alternative: Sodium nitroprusside (use with extreme caution due to thiocyanate toxicity risk)

Aortic dissection: 1, 3

• First-line: Esmolol (250-500 mcg/kg/min IV bolus, then 50-100 mcg/kg/min infusion) PLUS nitroprusside or nitroglycerin
• Critical principle: Beta blockade must precede vasodilator to prevent reflex tachycardia
• Alternative: Labetalol alone

Eclampsia/preeclampsia: 1, 3

• First-line: Labetalol or nicardipine PLUS magnesium sulfate
• Absolutely contraindicated: ACE inhibitors, ARBs, nitroprusside

Hypertensive encephalopathy: 1, 3

• First-line: Nicardipine (superior because it leaves cerebral blood flow intact and does not increase intracranial pressure)
• Alternative: Labetalol

Acute ischemic stroke: 1, 3

• If BP >220/120 mmHg: Reduce MAP by 15% within 1 hour using labetalol or nicardipine
• If eligible for thrombolysis and BP >185/110 mmHg: Carefully lower to <180/105 mmHg
• Critical warning: Avoid BP reduction within first 5-7 days unless BP exceeds 220/120 mmHg

Intracerebral hemorrhage: 1, 3

• If SBP ≥220 mmHg: Carefully lower to 140-160 mmHg immediately (within 6 hours) to prevent hematoma expansion
• Preferred agents: Labetalol, nicardipine

Medications to AVOID

Never use in hypertensive emergency: 1, 6, 8

• Immediate-release nifedipine: Unpredictable precipitous drops, reflex tachycardia
• Hydralazine (except eclampsia): Unpredictable response, prolonged duration
• Sodium nitroprusside (except as last resort): Cyanide and thiocyanate toxicity, especially with prolonged use >48-72 hours or renal insufficiency

---

Management of Hypertensive Urgency

Hypertensive urgency does NOT require hospital admission or IV medications. 1, 2

Outpatient Oral Management

For non-Black patients: 1

1. First-line: Low-dose ACE inhibitor or ARB
2. Second-line: Add dihydropyridine calcium channel blocker
3. Third-line: Add thiazide or thiazide-like diuretic

For Black patients: 1

1. First-line: Low-dose ARB plus dihydropyridine calcium channel blocker OR calcium channel blocker plus thiazide/thiazide-like diuretic
2. Third-line: Add the missing component (diuretic or ARB/ACEI)

Target BP: <130/80 mmHg (or <140/90 mmHg in elderly/frail) within 3 months 1

Follow-up: Arrange outpatient follow-up within 2-4 weeks to assess response 1, 2

---

Special Considerations for Resistant Hypertension or Heart Failure

Resistant Hypertension with Hypertensive Emergency

• Screen for secondary causes after stabilization: 20-40% of malignant hypertension cases have secondary causes including renal artery stenosis, pheochromocytoma, primary aldosteronism 1, 3
• Address medication non-compliance: Most common trigger for hypertensive emergencies 1
• Long-term management: Combination therapy with RAS blockers, calcium channel blockers, and diuretics typically needed 1

Heart Failure with Hypertensive Emergency

• Add IV loop diuretics (furosemide) for volume reduction in patients with significant fluid overload 1
• Continue oral beta blockers during hospitalization unless recent initiation/uptitration or marked volume overload 1
• Consider reduction or temporary discontinuation of ACE inhibitors, ARBs, and/or aldosterone antagonists in patients with worsening azotemia until renal function improves 1
• Monitor: Daily weight, fluid input/output, serial electrolytes, renal function 1

Renal Failure with Hypertensive Emergency

• First-line IV agent: Labetalol (provides controlled BP reduction in renal involvement) 1, 2
• Volume management: Intravenous saline may be needed to correct precipitous BP falls from pressure natriuresis 1
• Long-term oral management: 1
  • ACE inhibitors or ARBs as first-line (start at very low doses due to unpredictable responses)
  • Use loop diuretics instead of thiazides when eGFR <30 mL/min/1.73m²
  • Target BP <130/80 mmHg to protect against progression of renal dysfunction

---

Critical Pitfalls to Avoid

• Do not treat the BP number alone without assessing for true hypertensive emergency: Many patients with acute pain or distress have transiently elevated BP that normalizes when the underlying condition is treated 1
• Do not lower BP to "normal" acutely: Patients with chronic hypertension have altered autoregulation and acute normalization can cause ischemic complications 1, 3
• Do not delay laboratory testing: Immediate assessment is crucial for appropriate management 1
• Do not use oral medications for initial management of hypertensive emergency: Requires IV therapy 1
• Do not overlook volume depletion: May occur from pressure natriuresis and require IV saline 1